Enabling Screening for All

We are the pioneer in portable eye screening technologies. Our handheld imaging devices and AI services help to improve access to eye screening for blinding eye diseases.

Read more
Optomed 20 years banner

20th ANNIVERSARY

Optomed since 2004

We were established 20 years ago, with the goal of improving the accessibility and efficiency of eye screenings, particularly in primary healthcare settings.

Optomed Aurora IQ handheld fundus camera in use.

LATEST NEWS

Now published

Optomed’s Financial Statements Bulletin 2023 is now published.

Diabetic retinopathy

The number of diabetics has been growing rapidly around the world and one third of them suffer from diabetic retinopathy, the most common cause of vision loss in working-age adults.

Diabetic retinopathy is treatable, if detected early. However, due to the limited number of ophthalmologists and eye screening services, majority of diabetics globally do not have access to regular screenings.

Read more

80%

of what we learn is through our eyes.¹

537

million diabetics worldwide.²

80%

of vision-related problems are preventable and treatable.³

¹ J. Zaba. Journal of Behavioral Optometry, Volume 22, 2011. ² International Diabetes Federation. IDF Diabetes Atlas 2021, 10th ed. ³ The World Health Organization Visual Impairment and blindness Fact Sheet N282 August 2014

Our solution to a global problem

Effective eye screening prevents diabetes-related blindness and reduces overall health care costs.

We develop innovative and affordable solutions to enable eye screening for all patients worldwide.

Optomed’s fundus cameras

Latest releases

Share Price
Nasdaq Helsinki Stock Exchange

Share Price
Nasdaq Helsinki Stock Exchange